Literature DB >> 9104949

Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases.

A N Crowson1, C M Magro.   

Abstract

Perniosis is a term applied to cold-induced painful or pruritic erythematous or violaceous acral papular or nodular lesions. We examined 39 skin biopsies from 38 patients who presented with acral purpuric lesions, suggesting a diagnosis of perniosis clinically or pathologically. The presence of a systemic or extracutaneous disease was established in 17 patients, including 5 with systemic lupus erythematosus (SLE), 3 with antiphospholipid antibodies, in 1 in whom there was underlying HIV disease, 2 with viral hepatitis, 2 with rheumatoid arthritis (RA), 2 with cryofibrinogenemia, 1 with hypergammaglobulinemia, 1 with iritis, and 1 with Crohn's disease. In the other 21 patients, the clinical presentations prompted further studies in 12, which showed a positive antinuclear antibody (ANA) in 10. A diagnosis of idiopathic perniosis (IP) was rendered in all 21 of these patients including those in whom a positive ANA was discovered, based on the absence of any other serological markers, signs, or symptoms indicative of a specific systemic disease complex; many had Raynaud's phenomenon, small joint arthralgias, atopy, or a family history of either connective tissue disease or Raynaud's disease. The histopathology of IP comprised a superficial and deep angiocentric lymphocytic infiltrate with papillary dermal edema and lymphocytic exocytosis directed to retia and acrosyringia. A few cases showed a mild vacuolopathic or lichenoid interface dermatitis, adventitial dermal mucinosis, lymphocytic eccrine hidradenitis, vascular ectasia, and thrombosis confined to dermal papillae capillaries. The biopsies from patients with iritis, RA, and Crohn's disease showed a granulomatous vasculitis and a granuloma annulare-like tissue reaction. The biopsies from the patients with SLE, cryofibrinogenemia, primary antiphospholipid antibody syndrome, and hypergammaglobulinemia shared a similar histopathology comprising an interface dermatitis, superficial and deep angiocentric and eccrinotropic lymphocytic infiltrates, vascular ectasia, and dermal mucinosis with prominent involvement of the eccrine coil. Many cases did not show features of IP, namely papillary dermal edema, thrombosis of dermal papillary capillaries, and lymphocytic exocytosis into the retia and acrosyringia. There was frequent vascular fibrin deposition involving reticular dermal vessels. The latter two variables were statistically significant discriminators between IP and in perniotic lesions observed in the setting of underlying systemic disease. With respect to the latter, some cases occurred in the setting of cold exposure and were designated by us as "secondary perniosis" (SP), whereas others showed no specific association with cold exposure and were designated as perniotic mimics (PMs) based exclusively on the gross and microscopic morphology of the lesions.

Entities:  

Mesh:

Year:  1997        PMID: 9104949     DOI: 10.1016/s0046-8177(97)90038-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  The skin as a critical window in unveiling the pathophysiologic principles of COVID-19.

Authors:  Cynthia Magro; Gerard Nuovo; J Justin Mulvey; Jeffrey Laurence; Joanna Harp; A Neil Crowson
Journal:  Clin Dermatol       Date:  2021-07-22       Impact factor: 3.541

Review 2.  Chilblains in Southern California: two case reports and a review of the literature.

Authors:  Rebecca Gordon; Anne M Arikian; Anita S Pakula
Journal:  J Med Case Rep       Date:  2014-11-22

3.  A new dermoscopic pattern for chilblain-COVID-19-like skin lesions in adolescents.

Authors:  Gabriella Fabbrocini; Maria Vastarella; Paola Nappa; Maria C Annunziata; Elisa Camela; Vincenzo Greco; Francesca Gaudiello; Maria Alessio; Luca Pierri; Andrea Catzola; Alfredo Guarino
Journal:  JAAD Case Rep       Date:  2020-10-01

Review 4.  Systemic and organ-specific immune-related manifestations of COVID-19.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2021-04-26       Impact factor: 20.543

5.  Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic.

Authors:  J López-Robles; I de la Hera; J Pardo-Sánchez; J Ruiz-Martínez; E Cutillas-Marco
Journal:  Clin Exp Dermatol       Date:  2020-08-07       Impact factor: 4.481

6.  SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.

Authors:  I Colmenero; C Santonja; M Alonso-Riaño; L Noguera-Morel; A Hernández-Martín; D Andina; T Wiesner; J L Rodríguez-Peralto; L Requena; A Torrelo
Journal:  Br J Dermatol       Date:  2020-08-05       Impact factor: 11.113

7.  Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Authors:  V Piccolo; I Neri; C Filippeschi; T Oranges; G Argenziano; V C Battarra; S Berti; F Manunza; A B Fortina; V Di Lernia; V Boccaletti; G De Bernardis; B Brunetti; C Mazzatenta; A Bassi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

8.  The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.

Authors:  C M Magro; J J Mulvey; J Laurence; S Sanders; A N Crowson; M Grossman; J Harp; G Nuovo
Journal:  Br J Dermatol       Date:  2020-09-15       Impact factor: 11.113

9.  Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.

Authors:  Christine J Ko; Malini Harigopal; William Damsky; Jeff R Gehlhausen; Marcus Bosenberg; Robert Patrignelli; Jennifer M McNiff
Journal:  J Cutan Pathol       Date:  2020-09-09       Impact factor: 1.458

Review 10.  A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.

Authors:  Athanassios Kolivras; Curtis Thompson; Ievgenia Pastushenko; Marisa Mathieu; Pascal Bruderer; Marine de Vicq; Francesco Feoli; Saadia Harag; Isabelle Meiers; Catherine Olemans; Ursula Sass; Florence Dehavay; Ali Fakih; Xuan-Lan Lam-Hoai; Alice Marneffe; Laura Van De Borne; Valerie Vandersleyen; Bertrand Richert
Journal:  J Cutan Pathol       Date:  2021-08-09       Impact factor: 1.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.